Literature DB >> 25215267

Animal Models of Psychosis: Current State and Future Directions.

Alexandra D Forrest1, Carlos A Coto1, Steven J Siegel1.   

Abstract

Psychosis is an abnormal mental state characterized by disorganization, delusions and hallucinations. Animal models have become an increasingly important research tool in the effort to understand both the underlying pathophysiology and treatment of psychosis. There are multiple animal models for psychosis, with each formed by the coupling of a manipulation and a measurement. In this manuscript we do not address the diseases of which psychosis is a prominent comorbidity. Instead, we summarize the current state of affairs and future directions for animal models of psychosis. To accomplish this, our manuscript will first discuss relevant behavioral and electrophysiological measurements. We then provide an overview of the different manipulations that are combined with these measurements to produce animal models. The strengths and limitations of each model will be addressed in order to evaluate its cross-species comparability.

Entities:  

Keywords:  Animal Model; Behavior; Electroencephalography; Pharmacological Manipulation; Psychosis; Transgenic Mice

Year:  2014        PMID: 25215267      PMCID: PMC4157659          DOI: 10.1007/s40473-014-0013-2

Source DB:  PubMed          Journal:  Curr Behav Neurosci Rep


  199 in total

1.  Modulation of MK-801-induced behaviour by noradrenergic agents in mice.

Authors:  A Harkin; K Morris; J P Kelly; J M O'Donnell; B E Leonard
Journal:  Psychopharmacology (Berl)       Date:  2001-03-01       Impact factor: 4.530

2.  Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile.

Authors:  D S Segal; R Kuczenski
Journal:  J Pharmacol Exp Ther       Date:  1999-10       Impact factor: 4.030

3.  Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats.

Authors:  Alessia Luoni; Sjoerd Hulsken; Greta Cazzaniga; Giorgio Racagni; Judith R Homberg; Marco A Riva
Journal:  Int J Neuropsychopharmacol       Date:  2012-11-20       Impact factor: 5.176

4.  Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-03-17       Impact factor: 7.853

Review 5.  The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research.

Authors:  Konrad Talbot
Journal:  Prog Brain Res       Date:  2009-11-20       Impact factor: 2.453

6.  Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids.

Authors:  Minae Niwa; Hanna Jaaro-Peled; Stephanie Tankou; Saurav Seshadri; Takatoshi Hikida; Yurie Matsumoto; Nicola G Cascella; Shin-ichi Kano; Norio Ozaki; Toshitaka Nabeshima; Akira Sawa
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

7.  Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation.

Authors:  Julia J Turnock-Jones; Carol A Jennings; Melanie J Robbins; Jane E Cluderay; Jackie Cilia; Juliet L Reid; Adam Taylor; Declan N C Jones; Piers C Emson; Eric Southam
Journal:  Synapse       Date:  2009-10       Impact factor: 2.562

8.  Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha.

Authors:  Thomas J Gould; Scott P Bizily; Jan Tokarczyk; Michele P Kelly; Steven J Siegel; Stephen J Kanes; Ted Abel
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

9.  Differentiation between MK-801- and apomorphine-induced stereotyped behaviors in mice.

Authors:  A Hitri; D A O'Connor; J M Cohen; D J Keuler; S I Deutsch
Journal:  Clin Neuropharmacol       Date:  1993-06       Impact factor: 1.592

Review 10.  The genetics and biology of DISC1--an emerging role in psychosis and cognition.

Authors:  David J Porteous; Pippa Thomson; Nicholas J Brandon; J Kirsty Millar
Journal:  Biol Psychiatry       Date:  2006-07-15       Impact factor: 13.382

View more
  16 in total

Review 1.  TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia.

Authors:  Kazunori Suzuki; Haruhide Kimura
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

2.  HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.

Authors:  Mario de la Fuente Revenga; Daisuke Ibi; Justin M Saunders; Travis Cuddy; Maryum K Ijaz; Rudy Toneatti; Mitsumasa Kurita; Terrell Holloway; Li Shen; Jeremy Seto; Mikhail G Dozmorov; Javier González-Maeso
Journal:  Neuroscience       Date:  2018-07-17       Impact factor: 3.590

Review 3.  Serotonergic system, cognition, and BPSD in Alzheimer's disease.

Authors:  Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong
Journal:  Neurosci Lett       Date:  2019-04-01       Impact factor: 3.046

Review 4.  Animal Models of Psychosis in Alzheimer Disease.

Authors:  Josh M Krivinko; Jeremy Koppel; Alena Savonenko; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-05-17       Impact factor: 4.105

5.  Medial prefrontal cortex Notch1 signalling mediates methamphetamine-induced psychosis via Hes1-dependent suppression of GABAB1 receptor expression.

Authors:  Tong Ni; Li Zhu; Shuai Wang; Weili Zhu; Yanxue Xue; Yingjie Zhu; Dongliang Ma; Hongyan Wang; Fanglin Guan; Teng Chen
Journal:  Mol Psychiatry       Date:  2022-06-22       Impact factor: 15.992

Review 6.  The use of antioxidant compounds in the treatment of first psychotic episode: Highlights from preclinical studies.

Authors:  Stefania Schiavone; Luigia Trabace
Journal:  CNS Neurosci Ther       Date:  2018-03-14       Impact factor: 5.243

7.  Targeted neural network interventions for auditory hallucinations: Can TMS inform DBS?

Authors:  Joseph J Taylor; John H Krystal; Deepak C D'Souza; Jason Lee Gerrard; Philip R Corlett
Journal:  Schizophr Res       Date:  2017-09-29       Impact factor: 4.939

8.  Neurobehavioral alterations in a mouse model of chronic partial sleep deprivation.

Authors:  Shiyana Arora; Ravinder Naik Dharavath; Yashika Bansal; Mahendra Bishnoi; Kanthi Kiran Kondepudi; Kanwaljit Chopra
Journal:  Metab Brain Dis       Date:  2021-03-19       Impact factor: 3.584

Review 9.  The neurobiology of methamphetamine induced psychosis.

Authors:  Jennifer H Hsieh; Dan J Stein; Fleur M Howells
Journal:  Front Hum Neurosci       Date:  2014-07-22       Impact factor: 3.169

Review 10.  A New Perspective on Delusional States - Evidence for Claustrum Involvement.

Authors:  Maria Cristina Patru; David H Reser
Journal:  Front Psychiatry       Date:  2015-11-09       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.